Funding for this research was provided by:
UK Medical Research Council (MRC) and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement, the Wellcome Trust (WT078927MA)
European and Developing Countries Clinical Trials Partnership (TA_05_40200_40203)
Received: 28 August 2019
Accepted: 12 February 2020
First Online: 22 February 2020
Ethics approval and consent to participate
: The Rubicon study, from which we derived the experimental data, was reviewed and approved by the Uganda Virus Research Institute, Research and Ethics Committee (UVRI-REC) and the Uganda National Council of Science and Technology (UNCT). All participants provided informed signed consent accepting to freely participate in this study.
: Not applicable.
: The authors declare that they have no competing interests.